Coronary Stents Market Size to Worth US$ 17.2 Billion by 2030 – Exclusive Report by Precedence Research

According to Precedence Research, during the forecast period of 2022 to 2030, the global coronary stents market is estimated to develop at a compound annual growth rate (CAGR) of 6.94%. The global coronary stents market was valued at USD 9.4 billion in 2021, and it is predicted to exceed USD 17.2 billion by 2030. The study investigates several elements and their consequences on the growth of the coronary stents market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1932

This report focuses on coronary stents market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall coronary stents market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

Report Scope of Coronary Stents Market

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of coronary stents, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of coronary stents has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the coronary stents market.

Some of the prominent players in the coronary stents market include:

• Medtronic plc
• Cook Medical
• B. Braun Melsungen AG
• Terumo Corporation
• Vascular Concepts
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina
• Biosensors International Group Limited
• Abbott
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1932

Segments Covered in the Report

By Product

• Bare Metal Stents
• Bioresorbable Vascular Scaffold
• Drug Eluting Stents
• Biodegradable
• Non-Biodegradable

By Deployment

• Self-Expandable
• Balloon expandable

By Biomaterial

• Metallic Biomaterials
• Polymers Biomaterials
• Natural Biomaterials

By End User

• Hospitals and surgical centers
• Specialty clinics
• Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Coronary Stents Market 

5.1. COVID-19 Landscape: Coronary Stents Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Coronary Stents Market, By Product

8.1. Coronary Stents Market, by Product, 2022-2030

8.1.1. Bare Metal Stents

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Bioresorbable Vascular Scaffold

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Drug Eluting Stents

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Biodegradable

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Non-Biodegradable

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Coronary Stents Market, By Deployment

9.1. Coronary Stents Market, by Deployment e, 2022-2030

9.1.1. Self-Expandable

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Balloon expandable

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Coronary Stents Market, By Biomaterial 

10.1. Coronary Stents Market, by Biomaterial, 2022-2030

10.1.1. Metallic Biomaterials

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Polymers Biomaterials

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Natural Biomaterials

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Coronary Stents Market, By End User 

11.1. Coronary Stents Market, by End User, 2022-2030

11.1.1. Hospitals and surgical centers

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Specialty clinics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Coronary Stents Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.1.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.1.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.2.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.2.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.3.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.3.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.4.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.4.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Deployment (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Biomaterial (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)

Chapter 13. Company Profiles

13.1. Medtronic plc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Cook Medical

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. B. Braun Melsungen AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Terumo Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Vascular Concepts

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. STENTYS SA

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. MicroPort Scientific Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Meril Life Sciences Pvt. Ltd

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Translumina

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Biosensors International Group Limited

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1932

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com